Modeling hepatitis B virus X-induced hepatocellular carcinoma in mice with the Sleeping Beauty transposon system.
Modeling hepatitis B virus X-induced hepatocellular carcinoma in mice with the Sleeping Beauty transposon system.
复制标题
DOI:
10.1002/hep.24091
复制
发表时间:
2011-03
期刊:
影响因子:
13.5
通讯作者:
Largaespada, David A.
中科院分区:
文献类型:
--
作者:
Keng, Vincent W.;Tschida, Barbara R.;Bell, Jason B.;Largaespada, David A.
The mechanisms associated with hepatitis B viral (HBV) induced hepatocellular carcinoma (HCC) remain elusive and currently, there are no well-established animal models to study this disease. Using the Sleeping Beauty transposon as a delivery system, we introduced an oncogenic component of HBV, namely the hepatitis B virus X (HBx) gene to the livers of fumarylacetoacetate hydrolase (Fah) mutant mice via hydrodynamic tail vein injections. Coexpression of the Fah cDNA from the transposon vector allows for the selective repopulation of genetically corrected hepatocytes in Fah mutant mice. The process of hydrodynamic delivery induces liver inflammation and the subsequent selective repopulation of hepatocytes carrying the transgene(s) can provide useful genetic information on the mechanisms of HBV-induced hyperplasia. Short hairpin RNA directed against the Trp53 gene (shp53) or other tumor suppressor genes, and oncogenes, like the constitutively active NRASG12V, can also be codelivered with HBx using this system to determine if oncogenic cooperation exists. In this study, we find that expression of HBx induced activation of β-catenin expression in hydrodynamically injected livers, indicating its association with the Wnt signaling pathway in HBV-induced hyperplasia. HBx coinjected with shp53 accelerated the formation of liver hyperplasia in these mice. As expected, constitutively active NRASG12V alone was sufficient to induce liver hyperplasia and its tumorigenicity was augmented when coinjected with shp53. Interestingly, HBx does not seem to cooperate with constitutively active NRASG12V in driving liver tumorigenesis. This system can be used as a model for studying the various genetic contributions of HBV to liver hyperplasia and finally HCC in an in vivo system.
登录
查看更多内容
影响因子:
11.2
作者:
Hoshida Y;Nijman SM;Kobayashi M;Chan JA;Brunet JP;Chiang DY;Villanueva A;Newell P;Ikeda K;Hashimoto M;Watanabe G;Gabriel S;Friedman SL;Kumada H;Llovet JM;Golub TR
通讯作者:
Golub TR
DOI:
10.1016/j.bbrc.2005.12.089
发表时间:
2006-02-17
影响因子:
3.1
作者:
Wu, BK;Li, CC;Tsai, TF
通讯作者:
Tsai, TF
影响因子:
46.9
作者:
Keng, Vincent W.;Villanueva, Augusto;Chiang, Derek Y.;Dupuy, Adam J.;Ryan, Barbara J.;Matise, Ilze;Silverstein, Kevin A. T.;Sarver, Aaron;Starr, Timothy K.;Akagi, Keiko;Tessarollo, Lino;Collier, Lara S.;Powers, Scott;Lowe, Scott W.;Jenkins, Nancy A.;Copeland, Neal G.;Llovet, Josep M.;Largaespada, David A.
通讯作者:
Largaespada, David A.
影响因子:
4.6
作者:
Bock, C. Thomas;Toan, Nguyen L.;Torresi, Joseph
通讯作者:
Torresi, Joseph
影响因子:
11.4
作者:
DORIA, M;KLEIN, N;SCHNEIDER, RJ
通讯作者:
SCHNEIDER, RJ